Amniotic Membranes Market is projected to grow at 9% CAGR through 2028 | FMI
The global Amniotic Membranes Market is worth US$ 1.4 Billion as of now and is expected to reach US$ 2.3 Billion by the year 2028 at a CAGR of 9% between 2022 and 2028.
With extensive research being conducted with respect to regenerative medicine and stem cell, the global amniotic membranes market is bound to grow on an unprecedented note in the upcoming period.
When it comes to burning injuries, anti-scarring and anti-inflammatory properties are important, so as to foster quicker healing. This is where amniotic membranes come to the rescue. Furthermore, they are used to treat various eye disorders like bullous keratopathy, glaucoma, cataract, corneal ulcers, bacterial keratitis, ocular dystrophy, corneal degeneration, eyelid reconstruction, and likewise. Plus, the fact that growing geriatric population calls for increase in ophthalmology surgeries can’t be ignored. Therefore, there won’t be any looking back for demand pertaining to tissue-based products in the years to come.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5044
Cryopreserved amniotic membrane is used in majority of visual surgeries, thereby helping in better recovery and curtailed eye inflammation. Dehydrated amniotic membranes are used to treat several surgical wounds, venous and pressure leg ulcers, and reconstruction procedures. Future Market Insights has walked through these facts with future prospects in its latest market study entitled ‘Amniotic Membranes Market’.
“Amniotic membrane is used to heal wounds due to pain reduction and bacteriostatic properties. The application areas include corneal ulcers, surgical wounds, pterygium excisions, conjunctiva surface, limbal stem cell deficiency, pressure and venous leg ulcers, and regenerative medicine. This factor is expected to render the amniotic membranes indispensable going forward”, says an analyst from Future Market Insights.
Key Takeaways from Amniotic Membranes Market
- North America holds more than 30% of the market share due to proper healthcare facilities coupled with majority of market participants present in the US.
- Europe stands second on this count. This could be reasoned with the fact that Europe’s healthcare system is funded publicly and there are regions going for adoption of universal health systems. Also, the WHO has certified that chronic respiratory diseases, cardiovascular diseases, cancer, and diabetes altogether contribute for more than 86% of the market revenue.
- Coming to the Asia-Pacific, India is expected to witness sizable growth in amniotic membranes market with rise in ocular surgeries. Cosmetic surgeries are also on the rise.
Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-5044
- AminoFix (developed by MiMedx Group Inc.) comes across as one of the dehydrated amniotic membranes used especially for various surgical incisions. It thus functions as barrier membrane and curtails formation of scar tissues. The American Society of Plastic Surgeons has stated that The US is subject to more than 17 Mn surgical cosmetic surgeries. Every single year.
- Integra Lifesciences, in 2020, tabled AmioniExcel Placental Allograft Membrane for expanding the portfolio of wound care.
- Amino Technology, in February 2022, put forth Dual Layer PallinGen X Membrane and PalinGen X Membrane – two new-fangled PallinGen membrane products. They would be catering to the patients contracting non-healing chronic and acute wounds and open surgical or complex wounds.
- Merakis Therapeutics LLC, in 2020, did launch Dermacyte Amniotic Wound Care Matrix. It could be referred to as a cross-linked human amniotic membrane allograft comprising an epithelial basal along with compact fibroblast layer.
- The US FDA, in 2018, approved regenerative medicine advanced therapy credited to AminoFix from MiMedx. It’s used for treating osteoarthritis.
- Organogenesis Inc., in 2021, came up with ReNu (an amniotic suspension). The US FDA also approved the Regenerative Medicine Advanced Therapy designation to be used in knee osteoarthritis.
- MiMedx, in 2021, got approval from the Japanese Ministry of Health, Labor and Welfare to commercialize EPIFIX in Japan.
Buy This Report: https://www.futuremarketinsights.com/checkout/5044
How does the Report get through?
- The research study is based on product type (cryopreserved amniotic membranes and lyophilized amniotic membranes), by application (surgical wounds, ophthalmology, and likewise), and by end-user (hospitals, specialized clinics, Ambulatory Surgical Centers, and Academic Research Centers).
- With growing awareness regarding the necessity of transplants, tissue-based products are witnessing an exorbitant demand. This trend is likely to bolster the amniotic membranes market.
Key companies profiled:
Integra LifeSciences Inc., MiMedx Group, Inc., Tissue-Tech Inc., Skye Biologics Inc., Katena Products Inc., Alliqua BioMedical Inc., Human Regenerative Technologies LLC, Amnio Technology LLC, Applied Biologics LLC
Key Segments Of Amniotic Membranes Market Industry Survey
Amniotic Membranes Market by Product Type:
- Cryopreserved Amniotic Membranes
- Lyophilized Amniotic Membranes
Amniotic Membranes Market by Application:
- Surgical Wounds
Amniotic Membranes Market by End User:
- Specialized Clinics
- Ambulatory Surgical Centres
- Academic Research Centres
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: email@example.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs